The pathologist performing the EndoPredict test has access to an assessment tool (the EndoPredict Report Generator (EPRG)) developed specifically for the test.
The web-based EndoPredict® Report Generator (EPRG) software calculates the test result and evaluates the quality controls. The 12 gene-molecular score is calculated using the relative expression levels of the informative genes. This is combined with the tumor size and the nodal status information entered by the operator to generate the EPclin Risk score. The resulting EPclin Risk Class is based on a cut-off value separating a high from a low risk of distant recurrence for the individual patient tested.
The up-to-date version of the web-based EPRG tool is available to users free of charge at any time.